MacroGenics

MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The combination of MacroGenics' technology platforms and protein engineering has allowed the Company to generate product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.